[HTML][HTML] Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

V Levina, AM Marrangoni, R DeMarco, E Gorelik… - PloS one, 2008 - journals.plos.org
Background Cancer stem cells (CSCs) are thought to be responsible for tumor regeneration
after chemotherapy, although direct confirmation of this remains forthcoming. We therefore …

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy

XDE Dong, N Ito, MT Lotze, RA DeMarco… - Journal of …, 2007 - journals.lww.com
We have recently demonstrated that cytolysis of human melanoma cells by immune effectors
(both NK and T cells) is associated with release of the nuclear chromatin protein, high …

Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells

R Lotfi, GI Herzog, RA DeMarco… - The Journal of …, 2009 - journals.aai.org
Eosinophils (Eos) are found at increased numbers within necrotic areas of tumors. We show
that necrotic material from cell lysates containing damage-associated molecular pattern …

The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2

ZS Guo, A Naik, ME O'Malley, P Popovic, R Demarco… - Cancer research, 2005 - AACR
The ability of cancer cells to evade apoptosis may permit survival of a recombinant vaccinia
lacking antiapoptotic genes in cancer cells compared with normal cells. We have explored …

Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3

…, T Klassen, K Dennis, RA DeMarco… - The Journal of …, 2002 - journals.aai.org
Screening expressed sequence tag databases for endothelial-specific homologs to human
junctional adhesion molecule (JAM) and A33-Ag, we identified a protein of 298 aa that …

Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1

RA DeMarco, MP Fink, MT Lotze - Molecular immunology, 2005 - Elsevier
Substantial attention has been paid to the role of the toll-like receptor (TLR) ligands of late
and their role in regulating the innate immune response. They serve as exogenous danger …

Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury

…, ND Critchlow, J Li, KJ Tracey, RA Demarco… - The Journal of …, 2006 - journals.aai.org
High mobility group box 1 (HMGB1) is a NF released extracellularly as a late mediator of
lethality in sepsis and as an early mediator of inflammation following injury. Here we …

High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector

BK Lucas, LM Giere, RA DeMarco, A Shen… - Nucleic acids …, 1996 - academic.oup.com
We have constructed expression vectors for Chinese hamster ovary (CHO) cells that
produce both selectable marker and recombinant cDNA from a single primary transcript via …

Cytolytic cells induce HMGB1 release from melanoma cell lines

N Ito, RA DeMarco, RB Mailliard, J Han… - Journal of Leucocyte …, 2007 - academic.oup.com
High mobility group box 1 (HMGB1) is one of the recently defined damage-associated
molecular pattern molecules, passively released from necrotic cells and secreted by activated …

Dealing with death: HMGB1 as a novel target for cancer therapy.

MT Lotze, RA DeMarco - Current opinion in investigational drugs …, 2003 - europepmc.org
High mobility group B1 (HMGB1) and its counter-receptor, receptor for advanced glycation
end products (RAGE), represent suitable targets for investigation, integrating many aspects of …